Translational Research in Ophthalmic Pathology
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: 31 October 2024 | Viewed by 1024
Special Issue Editor
2. Department of Pathology, Section Ophthalmic Pathology, Erasmus University Medical Center, Doctor Molewaterplein 40, 3015 GD Rotterdam, The Netherlands
3. Department of Pathology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands
Interests: ocular oncology; neuro-oncology; autoimmune periorbital disease
Special Issue Information
Dear Colleagues,
The field of ophthalmic pathology is confined to the work of a select number of ophthalmologists and pathologists worldwide. Nevertheless, structures as diverse as the eyelids, conjunctiva, orbit, and the diverse tissues of the globe, cornea, sclera, uvea, retina, lens, and optic nerve can give rise to a host of different diseases but even significant advances in the knowledge of anatomy, histology, diagnostic histopathology, pathophysiology, or (epi) genetics prove to be difficult to publish. This Special Issue, with its focus on molecular-level investigations, invites authors to submit tissue-based translational research that aims to elucidate the molecular pathophysiology of diseases of the eye and orbit. Rare as these may be, a better understanding of molecular histopathology and pathophysiology is essential for improving the diagnosis and, ultimately, treatment of patients.
Dr. Robert M. Verdijk
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- eye
- ophthalmology
- immunohistochemistry
- molecular biology
- pathophysiology
- translational science
- anatomy
- histology
- pathology
- orbit
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
